NextCure is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. We view the immune system holistically and, rather than target one specific immune cell type, we focus on understanding biological pathways, the interactions of cells and the role each interaction plays in an immune response. Through our proprietary Functional, Integrated, NextCure Discovery in Immuno-Oncology, or FIND-IO, platform, we study various immune cells to discover and understand targets and structural components of immune cells and their functional impact in order to develop immunomedicines. We are focused on patients who do not respond to current therapies, patients whose cancer progresses despite treatment and patients with cancer types not adequately addressed by available therapies.
Company Details
- Employees
- 52
- Address
- 9000 Virginia Manor Rd,
- Phone
- (240)264-1250
- bu****@****ure.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- nextcure.com
- HQ
- Beltsville, Maryland
Nextcure, Inc. Questions
Nextcure, Inc.'s helpline number is (240)264-1250
Nextcure, Inc.'s website is nextcure.com
Nextcure, Inc.'s LinkedIn profile is https://www.linkedin.com/company/nextcure-inc
Nextcure, Inc. has
52 employees.
View email and phone details for 52
employees at Nextcure, Inc..
Nextcure, Inc.'s industry is
Biotechnology Research
Nextcure, Inc.'s top competitors are
Capstan Therapeutics,
Astrazeneca,
Oncoc4, Inc.,
Emergent Biosolutions,
Arcellx,
Novavax,
Georgiamune Inc.,
Catalent,
Macrogenics, Inc.,
Precigen.
Nextcure, Inc.'s support email address is busdev@nextcure.com
Nextcure, Inc.'s categories are Biotechnology Research
